| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $452M | — | $305M | — | 47.9% |
| Op. Income | $20M | — | $28M | — | -26.9% |
| Gross Margin | 29.5% | — | 37.1% | — | -7.6pp |
| Net Margin | 4.6% | — | 8.1% | — | -3.5pp |
| EPS (Diluted) | $0.34 | — | $0.44 | — | -22.7% |
| Free Cash Flow | $9M | — | $25M | — | -63.3% |
| Item | Amount |
|---|---|
| REVENUE | $452M |
| Cost of Revenue | $318M |
| GROSS PROFIT | $133M |
| R&D Expenses | $47M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $66M |
| Other Expenses | $0 |
| Operating Expenses | $113M |
| Cost & Expenses | $431M |
| OPERATING INCOME | $20M |
| Interest Income | $0 |
| Interest Expense | $5M |
| Other Income/Expenses | -$1M |
| INCOME BEFORE TAX | $19M |
| Income Tax Expense | -$2M |
| Net Income from Continuing Ops | $21M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $21M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $21M |
| D&A | $24M |
| EBIT | $23M |
| EBITDA | $47M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $452M |
| Cost of Revenue | $318M |
| GROSS PROFIT | $133M |
| R&D Expenses | $47M |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $66M |
| Other Expenses | $0 |
| Operating Expenses | $113M |
| Cost & Expenses | $431M |
| OPERATING INCOME | $20M |
| Interest Income | $0 |
| Interest Expense | $5M |
| Other Income/Expenses | -$1M |
| INCOME BEFORE TAX | $19M |
| Income Tax Expense | -$2M |
| Net Income from Continuing Ops | $21M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $21M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $21M |
| D&A | $24M |
| EBIT | $23M |
| EBITDA | $47M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $21M |
| Depreciation & Amortization | $24M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | -$4M |
| Other Non-Cash Items | $8M |
| Change in Working Capital | -$28M |
| OPERATING CASH FLOW | $21M |
| Capital Expenditure | -$11M |
| Acquisitions (Net) | -$105M |
| Purchases of Investments | -$20M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | $0 |
| NET CASH FROM INVESTING | -$136M |
| Net Debt Issuance | -$1M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | $0 |
| Other Financing Activities | $0 |
| NET CASH FROM FINANCING | $163M |
| FREE CASH FLOW | $9M |
| Net Change in Cash | $49M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $169M |
| Short-Term Investments | $16M |
| Net Receivables | $116M |
| Inventory | $45M |
| Other Current Assets | $38M |
| TOTAL CURRENT ASSETS | $386M |
| PP&E (Net) | $81M |
| Goodwill | $170M |
| Intangible Assets | $54M |
| Long-Term Investments | $8M |
| Tax Assets | $16M |
| Other Non-Current Assets | $27M |
| TOTAL NON-CURRENT ASSETS | $355M |
| TOTAL ASSETS | $740M |
| Account Payables | $32M |
| Short-Term Debt | $5M |
| Deferred Revenue | $72M |
| Other Current Liabilities | $101M |
| TOTAL CURRENT LIABILITIES | $210M |
| Long-Term Debt | $3M |
| Deferred Revenue NC | $67.0K |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $24M |
| TOTAL NON-CURRENT LIABILITIES | $30M |
| TOTAL LIABILITIES | $240M |
| Common Stock | $4M |
| Additional Paid-In Capital | $1.1B |
| Retained Earnings | -$615M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$4M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $500M |
| Minority Interest | $0 |
| TOTAL EQUITY | $500M |
| TOTAL LIABILITIES & EQUITY | $740M |
| Total Debt | $11M |
| Net Debt | -$158M |
